-
Oncoscience AG announces completion of patient enrollment in phase III trial of NIMOTUZUMAB, in first line treatment of children with inoperable brain cancer
Oncoscience | September 12th, 2007
Clearance Received for Two Additional Late-Stage Trials in Adult Glioma and Pancreatic Cancer Today Oncoscience AG (Wed...